Published today in the EClinicalMedicine Journal, a study from the University of Minnesota found that the first four months of the Minnesota Mobile Resuscitation Consortium…
MedicallyPrime.Com
A drug that has shown promise for treating multiple sclerosis may actually make the debilitating disease worse, new research from the University of Virginia School…
Following Pfizer’s announcement of 90%-plus efficacy for its COVID-19 vaccine, some Americans could conceivably start getting it in December, HHS Secretary Alex Azar said. (Reuters)…
The overall rate of severe gastrointestinal (GI) complications in COVID-19 patients admitted to the intensive care unit (ICU) was only 5.1%, investigators from the North…
Adding an anti-interleukin (IL)-8 neutralizing antibody to nivolumab (Opdivo) produced preliminary clinical activity in a small trial primarily involving patients previously treated with PD-1/L1 inhibitors.…
Welcome to Ethics Consult — an opportunity to discuss, debate (respectfully), and learn together. We select an ethical dilemma from a true patient care case.…
EL PASO, Texas — Bert Johansson, MD, was a pediatric critical care physician in New York City for 13 years before relocating here in 2009.…
Fish oil supplements and vitamin D didn’t reduce incidence of atrial fibrillation (Afib, AF) in a primary prevention setting in the VITAL-Rhythm trial. In fact,…
Enlarge this image Kristen Uroda for NPR Ms. Chavez was barely sustaining her oxygen levels despite being on maximum support through the thick tubing in…
Doctor’s orders are going virtual. With Covid-19 case counts on the rise again, Teladoc, a stock at the crossroads of health care and technology, could…